A number of research firms have changed their ratings and price targets for BrightSpring Health Services (NASDAQ: BTSG):
- 5/9/2026 – BrightSpring Health Services was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 5/6/2026 – BrightSpring Health Services had its price target raised by Morgan Stanley from $48.00 to $62.00. They now have an “overweight” rating on the stock.
- 5/5/2026 – BrightSpring Health Services had its price target raised by Mizuho from $52.00 to $61.00. They now have an “outperform” rating on the stock.
- 5/4/2026 – BrightSpring Health Services was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”.
- 5/4/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $60.00 price target on the stock.
- 5/4/2026 – BrightSpring Health Services had its price target raised by TD Cowen from $60.00 to $65.00. They now have a “buy” rating on the stock.
- 5/4/2026 – BrightSpring Health Services had its price target raised by Stephens from $53.00 to $64.00. They now have an “overweight” rating on the stock.
- 5/4/2026 – BrightSpring Health Services had its price target raised by KeyCorp from $55.00 to $60.00. They now have an “overweight” rating on the stock.
- 5/4/2026 – BrightSpring Health Services had its price target raised by Wells Fargo & Company from $50.00 to $61.00. They now have an “overweight” rating on the stock.
- 5/4/2026 – BrightSpring Health Services had its price target raised by BTIG Research from $55.00 to $65.00. They now have a “buy” rating on the stock.
- 5/1/2026 – BrightSpring Health Services had its price target raised by BMO Capital Markets from $52.00 to $60.00. They now have an “outperform” rating on the stock.
Insider Activity
In other BrightSpring Health Services news, CFO Jennifer A. Phipps sold 35,000 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $1,440,250.00. Following the completion of the transaction, the chief financial officer directly owned 196,840 shares of the company’s stock, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Lisa A. Nalley sold 30,000 shares of BrightSpring Health Services stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,234,500.00. Following the transaction, the insider owned 110,594 shares in the company, valued at approximately $4,550,943.10. This trade represents a 21.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 285,000 shares of company stock worth $11,727,750 over the last three months. Corporate insiders own 2.80% of the company’s stock.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.
Recommended Stories
- Five stocks we like better than BrightSpring Health Services
- Corpay’s Quiet Strength Is Winning Wall Street
- Investors Abandoned These 3 AI Stocks Too Early, Says Jeff Clark
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
Receive News & Ratings for BrightSpring Health Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services Inc and related companies with MarketBeat.com's FREE daily email newsletter.
